Our Business Model

With our extensive range of partnering options, we’re confident you will find the right fit for your business needs with DKSH Own Brands.

Driving Growth through Smart Partnerships, Licensing, and Strategic Alliances

Mergers & Acquisitions

Direct acquisition of strategic brands/portfolios with end-to-end integration capabilities.

In-Licensing

Long term exclusive rights of an asset with/without trademark rights. Directly accountable for end-to-end brand deliverables including MA ownership, distribution, regulatory approvals, market access, and commercialization success.

Out-Licensing

Strategic partnership to grant rights to commercialize our assets through a co-promotion/co-marketing model to maximize outreach.

NPP Model

A bespoke offering for Rare Disease specialty companies to enable early experience building pre-registration approval.

OEM (Toll) Manufacturing

Toll manufacturing of solid, liquid, semi-solid, and powder pharmaceutical products in a PIC/S GMP certified plant in Thailand, ensuring full regulatory compliance and high-quality production.

Strategic Alliance/Partnerships

Create an overall win-win situation where we complement partners’ commercialization and infrastructure needs in strategic acquisition deals.

Looking to Divest and Find a Partner to Sustain or Grow Your Brands?

DKSH Healthcare Own Brands can be your solution.

Expanding with well-established brands across classifications since 2019.

Free cash flow dedicated to M&A.

Added from recent Rx acquisition (2 brands in 9 markets).

Time to commercialization/integration.

Proven brand revitalization (Myonal example).

M&A Expertise and Life Cycle Management

Leading Commercial Platform

Unmatched reach across 62 markets with deep local expertise.

End-to-end M&A & 
In-Licensing Execution

Seamless handling of complex deals by a dedicated cross-functional expert team, with deal closing expected 1 month after signing.

Smooth Integration

Proven experience in seamless brand transitions, successfully integrating 9 markets in 1 program with minimal disruption.

Life Cycle Management Excellence

Strong track record in extending brand value through innovation.

Proven Global Leadership

Our leadership team has deep pharma and commercial expertise, with each executive bringing 15–20+ years of experience across regional and local roles.

Your Trusted Partners for
Global Divestments and Licensing

Contact us to discover new opportunities. 

Contact Us